| [1] |
Gong Jiashun;Zhang Yanling;Chen Hao.
Safety and efficacy of rifaximin versus nonabsorbable disaccharides in treatment of hepatic encephalopathy:a meta analysis
[J]. Clinical Focus, 2015, 30(2): 191-195.
|
| [2] |
.
[J]. Clinical Focus, 2012, 27(8): 706-707.
|
| [3] |
.
[J]. CLINICAL FOCUS, 2007, 22(13): 985-987.
|
| [4] |
.
[J]. CLINICAL FOCUS, 2006, 21(13): 936-0.
|
| [5] |
.
[J]. CLINICAL FOCUS, 2005, 20(4): 216-217.
|
| [6] |
.
[J]. CLINICAL FOCUS, 2004, 19(21): 1202-1204.
|
| [7] |
.
[J]. CLINICAL FOCUS, 2003, 18(7): 366-366.
|
| [8] |
.
[J]. CLINICAL FOCUS, 2002, 17(9): 512-512.
|
| [9] |
.
[J]. CLINICAL FOCUS, 2002, 17(7): 396-397.
|
| [10] |
.
[J]. CLINICAL FOCUS, 2002, 17(7): 398-399.
|
| [11] |
.
[J]. CLINICAL FOCUS, 2002, 17(5): 259-259.
|
| [12] |
.
[J]. CLINICAL FOCUS, 2002, 17(3): 137-138.
|
